Clinical Trial Update: European Registry on STEMI Patients Transferred for PCI With Upstream Use of Abciximab - EuroTransfer Registry

View source ↗

Summary

A completed European registry study evaluating upstream abciximab use in STEMI patients transferred for PCI (EuroTransfer Registry).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• St-elevation Myocardial Infarction

Drugs mentioned

• Abciximab (abciximab)

Snippet

Sponsor: Jagiellonian University | Conditions: ST-Elevation Myocardial Infarction, Acute Coronary Syndrome | Status: COMPLETED